Categories
Pharmaceutical

Lung Cancer Diagnostics Market is Expected to Witness Healthy Growth at 7.3% CAGR through 2031

A recent study by Fact.MR on the lung cancer diagnostics market offers a 10-year forecast for 2021 to 2031.

Bottom-up approach is always used to obtain Lung Cancer Diagnostics insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Lung Cancer Diagnostics market and quantified with insightful rationale.

Increasing prevalence of diseases across the globe is generating huge demand for advanced healthcare system. As a result, more and more technologically advanced medical devices are being employed to aid medical Practitioners and professionals in medical setups. Sales of Lung Cancer Diagnostics devices are soaring rapidly.

The Demand analysis of Lung Cancer Diagnostics Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Lung Cancer Diagnostics Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Segmentation:

Test Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

End-User

  • Lung Cancer Diagnostics  for Hospital Associated Labs
  • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
  • Lung Cancer Diagnostics for Cancer Research Institutes
  • Others

Indication

  • Non-Small-cell Lung Cancer Diagnostics
  • Small-cell Lung Cancer Diagnostics

Technological Innovation in Medical Devices Revolutionizing the Healthcare System

The medical device industry is a heterogeneous, innovative and dynamic sector. From telemedicine to artificial intelligence, robotic surgery and 3D printing, technology is revolutionizing the healthcare industry.

The intersection of healthcare and technology has led to numerous advancements in medical devices. New age medical technology has transformed the way doctors and patients participate and interact with each other. Introduction of advanced medical devices such as drug-device combinations (DDCs), preventive and predictive equipment’s, self-care devices is completely transforming the medical world.

Increasing investments by public and government bodies in healthcare sector is positively impacting the Lung Cancer Diagnostics market. Governments across the globe are introducing various initiatives to strength the medical device sector with major emphasis on research and development (R&D).

Lung Cancer Diagnostics manufacturing companies and healthcare service providers have started offering personalized patient care and access to complete end-to-end medical device products and services. They are focusing on developing and enhancing product prototyping and minimizing operation cost.

With the onset of COVID-19 pandemic the sales of Lung Cancer Diagnostics witnessed a huge upsurge and the trend is likely to continue in the future.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Competitive Landscape

Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, technological advances for cancer screening, mergers, and acquisitions.

  • In March 2021, Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. collaborated with Illumina, Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer, using Illumina’s NextSeq™ 550Dx sequencing platform.
  • In Jan 2017, Abbott Laboratories completed largest the acquisition of St.Jude Medical for US$ 25 Bn. Together, the company will compete in nearly every area of the $30 billion cardiovascular markets and hold the No. 1 or 2 positions across large and high-growth cardiovascular device markets

Some Notable Offerings by Fact.MR Report on Lung Cancer Diagnostics market:

  • We will provide you an analysis of the extent to which this Lung Cancer Diagnostics market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Report Benefits & Key Questions Answered

  • Lung Cancer Diagnostics Category and segment level analysis: Fact MR offers detailed analysis of the factors influencing the sales prospect across key segments. Lung Cancer Diagnostics category analysis provides deep insights into customer experiences, emerging trends and growth drivers. The vital information highlighted in this section will enable market players to make timely business decision to gain competitive advantage.
  • Lung Cancer Diagnostics Manufacturing trend analysis: A key aspect of the study is comprehensive Lung Cancer Diagnostics manufacturing trend analysis. These insights provide vital information on how market players are coping with latest trends that are prevailing in the market.
  • Innovation and acquisition activity in Lung Cancer Diagnostics: The report highlights in detail the various organic and inorganic strategies adopted manufacturers in order to gain a competitive edge in Lung Cancer Diagnostics market. Adoption of various technologies are being discussed in detail.
  • Lung Cancer Diagnostics demand by country: The report forecasts the country wise demand for Lung Cancer Diagnostics between 2021 and 2031. By analyzing this section of the report, Lung Cancer Diagnostics manufacturers can accordingly invest in those regions where the demand is on the rise.
  • Post COVID consumer spending on Lung Cancer Diagnostics: The Fact.MR market survey also highlights the impact of COVID-19 on medical devices industry. These insights provide vital information on how market players are executing their manufacturing strategies to coup with the COVID-19 pandemic.

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

  1. North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
  2. Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
  3. CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
  4. Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
  5. Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
  6. Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
  7. Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
  8. Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
  9. Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

To get all-in insights on the regional landscape of the Lung Cancer Diagnostics Market, Buy Now:-https://www.factmr.com/checkout/49

After reading the Market insights of Lung Cancer Diagnostics Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Lung Cancer Diagnostics market revenue.
  • Study the growth outlook of Lung Cancer Diagnostics market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Lung Cancer Diagnostics market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Lung Cancer Diagnostics Market Players.

Read More Trending Reports of Fact.MR: – https://www.biospace.com/article/breast-cancer-diagnostics-market-sales-set-to-grow-by-4-7-percent-to-surpass-us-2000-mn-by-2022-end-fact-mr

How Fact.MR Assists in Making Strategic Moves For Lung Cancer Diagnostics Market Manufacturer?

  • The data provided in the Lung Cancer Diagnostics market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

 More Related Reports by Fact.MR On Healthcare Sector: 

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Demand for Lung Cancer Diagnostics CA Test Is Expected to Reach US$ 889.3 Mn by the End of 2022

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to a recent report by Fact.MR, the global demand for lung cancer diagnostics is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

  1. North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
  2. Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
  3. CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
  4. Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
  5. Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
  6. Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
  7. Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
  8. Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
  9. Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

Fact.MR’s report profiles key market players, which include

Illumina, Inc.
Abbott Laboratories
Thermo Fischer Scientific Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
NeoGenomics Laboratories, Inc.
NanoString Technologies, Inc.
Myriad Genetics, Inc.
Roche Holding AG
Danaher Corporation.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=49

Global Lung Cancer Diagnostics Market: Segmentation

For clearer understanding of the Lung Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Lung Cancer Diagnostics Market, which is essential to make sound investments.

Market Taxonomy

Test Type End User Indication
CA Test Hospital Associated Labs Non Small-cell Lung Cancer
HER2 Tests Independent Diagnostic Laboratories Small-cell Lung Cancer
ALK Tests Cancer Research Institutes
Angiogenesis Inhibitor Others
EGFR Mutation Tests
KRAS Mutation Tests
Others

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Lung Cancer Diagnostics Market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Segmentation:

Test Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

End-User

  • Lung Cancer Diagnostics  for Hospital Associated Labs
  • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
  • Lung Cancer Diagnostics for Cancer Research Institutes
  • Others

Indication

  • Non-Small-cell Lung Cancer Diagnostics
  • Small-cell Lung Cancer Diagnostics

Following Questions Answers Covered in the Report are:

  • How will the global Lung Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Lung Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Lung Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

 

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/17/2001947/0/en/Sales-of-Automotive-Wrap-Films-to-Expand-6X-Between-2019-and-2029-MEA-Poised-to-Turn-Highly-Lucrative-Forecasts-a-New-Fact-MR-Report.html

 

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Lung Cancer Diagnostics Market report answers the following queries:

  1. What is the largest share held by key players in the market?
  2. What strategies have proven most advantageous in the Lung Cancer Diagnostics Market?
  3. Which region promises largest opportunity for new investors during the forecast period 2021 to 2031?
  4. What factors will most likely present challenges to growth during the forecast period?
  5. What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2021 to 2031?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com